SARS-CoV-2-antigeenin pikatestisarja

Tuotteen Kuvaus


SARS-COV2-antigeenin nopea testikortti sisältää kullalla leimatun uuden koronavirus N -proteiinimonoklonaalisen vasta-aineen, joka on esipäällystetty sitoutumistyynylle, ja pariksi yhdistetyn uuden koronaviruksen N-proteiinin monoklonaaliset vasta-aineet, jotka on kiinnitetty testilinjaan (T), ja vastaavat vasta-aineet laadunvalvontalinjassa. (C).

SARS-COV2 Antigen Rapid Test Kit -paketti pystyy havaitsemaan viruksen tartunnan ensimmäisestä vaiheesta (2-3 päivää ennen mahdollisten oireiden alkamista) infektion viimeiseen vaiheeseen (7-10 päivää mahdollisten oireiden alkamisesta).

• Käytetään COVID-19-antigeenin testaamiseen

• Korttimainen muoto, havaitsee viruksen nukleokapsidi (N) -proteiinin.

• Kultaleimatut SARS-CoV-2 N -proteiinimonoklonaaliset vasta-aineet, jotka on immobilisoitu testi-alueelle vastaavien vasta-aineiden kanssa laadunvalvonta-alueella.

• Pyyhkäisyt näytteet nenänielusta tai suunielusta, tuloksena 15 minuuttia.

Tuotteen ominaisuudet


• Tunkeilematon

• Helppo käyttää

• Kätevä, ei tarvita laitteita

• Nopea, saat tuloksen 15 minuutissa

• Vakaa, erittäin tarkasti

• Edullinen, kustannustehokas

SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] 100 ul

BSV-COV-AB-02 100 ul
EUR 602
Description: SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] (Spike (S2), Monoclonal)

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-1 1T
EUR 9.6
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again.

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-25 25T/kit
EUR 42
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-100g 100 µg
EUR 850

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-20g 20 µg
EUR 100

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-50g 50 µg
EUR 450

SARS-CoV-2 Antigen Rapid Test Kit

GF101A2 25 Test/kit Ask for price

SARS-CoV-2 Rapid Antigen Test Nasal

9901-NCOV-03G 25 Tests/Kit
EUR 112.8
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

SARS-CoV-2 RBD antigen-coated beads

IMS0510 96
EUR 247.5
Description: Single Receptor-binding domain of S-glycoprotein (RBD) coated beads

SARS CoV-2 RT PCR kit

RTq-H731-100R 100T
EUR 1573.2

SARS CoV-2 RT PCR kit

RTq-H731-150R 150T
EUR 2144.4

SARS CoV-2 RT PCR kit

RTq-H731-50R 50T
EUR 1155.6

OAEF00177-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody

OAEF00177-1MG 1mg
EUR 471

OAEF00179-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody

OAEF00179-1MG 1mg
EUR 471

OAEF00193-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody

OAEF00193-1MG 1mg
EUR 471

OAEF00194-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody

OAEF00194-1MG 1mg
EUR 471

OAEF00195-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody

OAEF00195-1MG 1mg
EUR 471

SARS-CoV-2 Spike antigen-coated beads

IMS0511 96
EUR 247.5
Description: Single stable trimer of the spicule glycoprotein (S) coated beads

Jätä kommentti